Clinical Trials · NCT01896011

Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures

CompletedPhase 3Teriparatide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
University Health Network, Toronto
Enrollment
34
Start date
Jul 2013
Locations
1 site, Canada
Primary endpoint
Change in the modified The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)of the affected limb (the femur that has the incomplete AFF)
View Teriparatide compound reference